Intensity Therapeutics Investor Relations Material
Latest events
AGM 2025
Intensity Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intensity Therapeutics Inc
Access all reports
Intensity Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of cancer immunotherapies. The company's lead platform is designed to deliver therapeutic agents directly into tumors to stimulate immune activation and systemic anti-cancer effects. Its development activities span preclinical research through clinical trials targeting various solid tumors. Intensity Therapeutics Inc is headquartered in Westport, Connecticut, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
INTS
Country
🇺🇸 United States